Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 065170
Company: SUN PHARMA CANADA

Products on ANDA 065170

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MUPIROCIN	MUPIROCIN	2%	OINTMENT;TOPICAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 065170

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/23/2005	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/21/2021	SUPPL-15	Labeling-Patient Package Insert, Labeling-Package Insert		Label is not available on this site.
07/21/2021	SUPPL-14	Labeling-Package Insert		Label is not available on this site.
11/18/2015	SUPPL-13	Labeling-Package Insert		Label is not available on this site.
11/18/2015	SUPPL-12	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 065170

MUPIROCIN

OINTMENT;TOPICAL; 2%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MUPIROCIN	MUPIROCIN	2%	OINTMENT;TOPICAL	Prescription	No	AB	217943	ENCUBE
MUPIROCIN	MUPIROCIN	2%	OINTMENT;TOPICAL	Prescription	No	AB	065192	FOUGERA PHARMS
MUPIROCIN	MUPIROCIN	2%	OINTMENT;TOPICAL	Prescription	No	AB	090480	GLENMARK PHARMS
MUPIROCIN	MUPIROCIN	2%	OINTMENT;TOPICAL	Prescription	No	AB	065123	PADAGIS ISRAEL
MUPIROCIN	MUPIROCIN	2%	OINTMENT;TOPICAL	Prescription	No	AB	065170	SUN PHARMA CANADA
MUPIROCIN	MUPIROCIN	2%	OINTMENT;TOPICAL	Prescription	No	AB	065085	TEVA